相关实验视频

Updated: May 12, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

5,6-二基黄通过阻止病毒进入宿主细胞来发挥抗贝塔冠状病毒活性

Yujia Cao¹, Kah Man Lai², Hongling Zheng¹

¹Department of Food Science and Technology, National University of Singapore, Singapore 117542, Singapore.

|April 25, 2025

概括

5,6-二基黄 (5,6-DHF) 对SARS-CoV-2 Omicron EG.5.1.1和其他β冠状病毒 (β-CoV) 具有强烈的抗病毒活性. 这种化合物通过阻断尖峰-ACE2相互作用来抑制病毒的进入,表明其作为治疗候选者的潜力.

科学领域:

病毒学病毒学
药用化学医学化学
药物发现药物发现药物发现

背景情况:

来自Scutellaria baicalensis Georgi的Baicalin通过准病毒3C类蛋白酶 (3CLpro) 来抑制SARS-CoV-2.
有限的数据存在于5,6-dihydroxyflavone (5,6-DHF) 的抗病毒潜力,一个baicalin类似物,对betacoronaviruses (beta-CoVs).

研究的目的:

为了研究5,6-DHF的抗SARS-CoV-2和抗β-CoV活性.
阐明5,6-DHF对SARS-CoV-2 Omicron变异EG.5.1.1.1.的作用机制.

主要方法:

微中和化试验 (MNT) 和斑块减少中和化试验 (PRNT) 用于评估抗病毒活性.
使用3CLpro抑制试验,添加时间试验,分子对接和伪型病毒进入试验来确定作用机制.
通过在5,6-DHF上修改基组来探索结构-活性关系.

主要成果:

5,6-DHF对SARS-CoV-2 Omicron变种EG.5.1.1的活性比baicalein.1.1更强.
在5,6-DHF的A环上的5,6-二氧 (甲基醇) 组对其抗病毒功效至关重要.
5,6-DHF通过干扰尖端蛋白的受体结合域 (RBD) 与ACE2.2的相互作用来抑制SARS-CoV-2的进入.
5,6-DHF还有效地抑制了人类β型冠状病毒OC43 (HCoV-OC43) 的进入.

结论:

5,6-DHF是SARS-CoV-2 Omicron变异EG.5.1.1和HCoV-OC43入口的强有力的抑制剂.
该化合物的机制涉及阻断尖峰-ACE2相互作用.
5,6-DHF显示为对抗各种β-CoVs的治疗候选物具有前途.

关键词:

5,6-二氧黄是一种5,6-二氧黄.这是一种抗冠状病毒药物.这种类型的酸盐是酸盐.接收器结合的域名域名这是SARS-Cov-2病毒.

更多相关视频

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...